Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

IND submitted for new atherosclerosis imaging agent from Diatide

Jan. 13, 1998

Diatide's acute thrombosis imaging agent scheduled for review by FDA panel

Jan. 12, 1998

Epix Medical's MRI contrast agent evaluated for breast cancer indications

Jan. 9, 1998

Novel diagnostic compositions reported by Amersham

Jan. 9, 1998

FDA clears Optison

Jan. 8, 1998

FDA approves first gene-based cancer diagnostic for U.S. market

Jan. 5, 1998

Enrollment complete in pivotal trial of P829 for lung cancer imaging

Jan. 5, 1998

Cytogen updates stockholders

Dec. 31, 1997

Geron and Boehringer Mannheim will jointly develop telomerase-based assays

Dec. 30, 1997

FDA requests more information for RIGScan CR49 BLA

Dec. 30, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...